Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-22
DOI
10.1038/s41379-020-00729-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PIK3CA gene aberrancy and role in targeted therapy of solid malignancies
- (2020) Owen Willis et al. CANCER GENE THERAPY
- Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study.
- (2020) Aurelien Marabelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status
- (2020) Basile Tessier-Cloutier et al. MODERN PATHOLOGY
- CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma
- (2020) Erik A. Williams et al. MODERN PATHOLOGY
- Treatment algorithm and prognostic factors for patients with stage I–III carcinoma of the anal canal: a 20-year multicenter study
- (2020) Diane Bruyere et al. MODERN PATHOLOGY
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinicopathologic Features of Anal and Perianal Squamous Cell Carcinomas and Their Relationship to Human Papillomavirus
- (2019) Jennifer Y. Ju et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- A Systematic Review and Meta-Analysis of Prognostic Biomarkers in Anal Squamous Cell Carcinoma Treated With Primary Chemoradiotherapy
- (2019) I. Parwaiz et al. CLINICAL ONCOLOGY
- HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma
- (2018) Paulo C. Soares et al. BMC GASTROENTEROLOGY
- Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015
- (2018) Elizabeth A. Van Dyne et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Heterogeneous mutational profile and prognosis conferred by TP53 mutations in Appendiceal mucinous neoplasms
- (2018) Xiaoqin Zhu et al. HUMAN PATHOLOGY
- Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
- (2017) Van K Morris et al. LANCET ONCOLOGY
- Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal
- (2017) Van Morris et al. MOLECULAR CANCER RESEARCH
- The prognostic value of HPV combined p16 status in patients with anal squamous cell carcinoma: a meta-analysis
- (2017) Guorui Sun et al. Oncotarget
- Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma
- (2017) Wulfran Cacheux et al. Oncotarget
- Human papillomavirus related anal squamous cell carcinoma survival: a systematic review and meta-analysis
- (2017) Jian-Ning Yao et al. Translational Cancer Research
- Basaloid Squamous Cell Carcinoma of the Anus Revisited
- (2016) Rondell P. Graham et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes
- (2016) J. H. Chung et al. ANNALS OF ONCOLOGY
- Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection
- (2016) Wulfran Cacheux et al. BRITISH JOURNAL OF CANCER
- Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors
- (2016) S. O. Dolly et al. CLINICAL CANCER RESEARCH
- Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma
- (2016) Kent W. Mouw et al. CLINICAL CANCER RESEARCH
- Human Papillomavirus Laboratory Testing: the Changing Paradigm
- (2016) Eileen M. Burd CLINICAL MICROBIOLOGY REVIEWS
- Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease
- (2016) Michal Kamionek et al. HISTOPATHOLOGY
- Somatic mutations in histiocytic sarcoma identified by next generation sequencing
- (2016) Qingqing Liu et al. VIRCHOWS ARCHIV
- HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
- (2015) D Meulendijks et al. BRITISH JOURNAL OF CANCER
- Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer
- (2015) Sabine Mai et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
- (2015) Mona Saraiya et al. JNCI-Journal of the National Cancer Institute
- Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal
- (2015) V. K. Morris et al. ONCOLOGIST
- Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas
- (2015) Brandon G. Smaglo et al. Oncotarget
- US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
- (2015) Mona Saraiya et al. JNCI-Journal of the National Cancer Institute
- Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience
- (2015) Ming-Mo Hou et al. Oncotarget
- No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16INK4a status
- (2014) Elena-Sophie Prigge et al. HUMAN PATHOLOGY
- Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors
- (2014) Filip Janku et al. Cell Reports
- Abstracts and Case Studies From the College of American Pathologists 2013 Annual Meeting (CAP ‘13)
- (2013) ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Clinicopathological analysis of basal cell carcinoma of the anal region and its distinction from basaloid squamous cell carcinoma
- (2013) Deepa T Patil et al. MODERN PATHOLOGY
- p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: Correlation with outcomes following chemo-radiotherapy
- (2013) Duncan C Gilbert et al. RADIOTHERAPY AND ONCOLOGY
- Cervista HR and HPV 16/18 Assays vs Hybrid Capture 2 Assay
- (2011) Elizabeth M. Kurian et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence
- (2011) H. D. Skinner et al. CLINICAL CANCER RESEARCH
- Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
- (2011) Anna Yemelyanova et al. MODERN PATHOLOGY
- Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review
- (2010) T Lampejo et al. BRITISH JOURNAL OF CANCER
- The role of mutant p53 in human cancer
- (2010) Amanda M Goh et al. JOURNAL OF PATHOLOGY
- Targeting p53 for enhanced radio- and chemo-sensitivity
- (2009) Chao Lu et al. APOPTOSIS
- Modified General Primer PCR System for Sensitive Detection of Multiple Types of Oncogenic Human Papillomavirus
- (2009) A. Soderlund-Strand et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status
- (2009) Nadine Lukan et al. ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now